Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
|Active Ingredients:||Ethinylestradiol 0.035mg
|New Zealand Sponsor:||Link Pharmaceuticals Limited|
|Manufacturer:||Teva Women’s Health Inc., Ohio, United States of America|
|Note: This consent is given subject to the following conditions:
|Note: This renewed consent is valid for six months from 4 December 2020.|
Dated this 29th day of October 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).